Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater disease » greater decrease (Expand Search), related disease (Expand Search), greater sense (Expand Search)
rates decrease » rate decreased (Expand Search), greatest decrease (Expand Search), greater decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater disease » greater decrease (Expand Search), related disease (Expand Search), greater sense (Expand Search)
rates decrease » rate decreased (Expand Search), greatest decrease (Expand Search), greater decrease (Expand Search)
-
1741
-
1742
-
1743
-
1744
Difference in theta power between breathing conditions and resting state for frontal midline ROI.
Published 2025Subjects: -
1745
Topographic maps of difference in alpha functional connectivity between breathing conditions.
Published 2025Subjects: -
1746
-
1747
Topographic maps of difference in theta power between breathing conditions.
Published 2025Subjects: -
1748
-
1749
Difference in alpha power between breathing conditions for left and right central-parietal ROI.
Published 2025Subjects: -
1750
Topographic maps of difference in individual alpha/mu power between breathing conditions.
Published 2025Subjects: -
1751
-
1752
-
1753
Difference in theta power between breathing conditions for frontal midline ROI.
Published 2025Subjects: -
1754
-
1755
Topographic maps of difference in theta functional connectivity between breathing conditions.
Published 2025Subjects: -
1756
-
1757
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
Published 2025“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
-
1758
-
1759
-
1760